Crossmark

The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles

Crossref DOI link: https://doi.org/10.1186/s13048-022-01009-w

Published Online: 2022-06-21

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Chunxia

Dong, Naijun

Li, Feng

Ji, Yurong

Pan, Yu

She, Hong
License Information

Text and Data Mining valid from 2022-06-21

Version of Record valid from 2022-06-21
More Information

Article History

Received: 21 March 2022

Accepted: 1 June 2022

First Online: 21 June 2022

Declarations

:

: This study was approved by the ethics committee of the Reproductive Medicine of Subei People’s Hospital of Jiangsu Province. Due to the retrospective nature, the need for informed consent was waived by the committee.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below